Azafaros has secured 132 million euros ($147 million) in series B funds that the Dutch biotech will use to push its rare ...

The uncertainty around splitting up the business is only the latest in a series of strategic shake-ups at Galapagos in recent years. Other major events have included the pivot to CAR-Ts in 2022 and ...